Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04704609 · ClinicalTrials.gov registry record
Imaging Quantification of Inflammation (IQI)
A clinical trial of Uveitis, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04704609: Active study of Uveitis, sponsored by The Cleveland Clinic.
NCT04704609 is a study of Uveitis that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 50 participants, below the 615-participant average among 19 other Uveitis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04704609, a study of Uveitis, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
1\. Perform observational study utilizing real-time quantification of ocular inflammation to determine minimal important change. Prospective use of changes in imaging quantification of inflammation (IQI) scores in determining treatment decisions both utilizing novel FA viewer software.
Primary Outcome
Perform observational study utilizing real-time quantification of ocular inflammation to determine minimal important change using FA viewer software.
Conditions Studied
Interventions
- OTHER Standard of Care Imaging
Study Locations (1)
Ohio
- Cleveland Clinic Foundation Cole Eye Institute - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-09-22 |
| Est. Completion | 2027-09-30 |
What the registry record for NCT04704609 still lists
NCT04704609 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 615-participant average among 19 other Uveitis trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Uveitis appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care Imaging is the first listed.
NCT04704609 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04704609 about?
NCT04704609 is a clinical study titled "Imaging Quantification of Inflammation (IQI)". 1\. Perform observational study utilizing real-time quantification of ocular inflammation to determine minimal important change. Prospective use of changes in imaging quantification of inflammation (IQI) scores in determining treatment decisions both utilizing novel FA viewer software.
What is the current status of trial NCT04704609?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2019-09-22. Estimated completion is 2027-09-30.
What conditions does trial NCT04704609 study?
This clinical trial studies the following conditions: Uveitis.
What interventions are being tested in trial NCT04704609?
The interventions under investigation include: Standard of Care Imaging (OTHER).
Who is sponsoring clinical trial NCT04704609?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04704609 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uveitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04704609's enrollment target sits among peer trials
50 14th of 19 higher than 6 of 19 other Uveitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uveitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
RECRUITING
-
Genetics of Uveitis
RECRUITING
-
Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
RECRUITING
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
RECRUITING · Phase 3
-
Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI